ASCL1 and glioblastoma: Furthermore, Narayanan proposed that ASCL1 might be served as potential subgroup-specific targetable vulnerability in GBM through targeting NDRG1 (Zhang et al., 2008; Stark, 2011; Bao et al., 2018; Ji et al., 2019; Bao et al., 2021).